The discovery of ACVR1 – a type I BMP receptor – as the causative gene in FOP acted as a catalyst of studies aimed at understanding the molecular and cellular aspects of the pathophysiology of this disease and also pinpointed ACVR1 as a new therapeutic target (see below). Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.